Investors in Ocular Therapeutix (NASDAQ:OCUL) have unfortunately lost 63% over the last year
yahoo.com
news
2022-10-17 12:11:35

Investing in stocks comes with the risk that the share price will fall. Unfortunately, shareholders of Ocular Therapeutix, Inc. (NASDAQ:OCUL) have suffered share price declines over the last year. The share price is down a hefty 63% in that time. On the bright side, the stock is actually up 20% in the last three years. Even worse, it's down 30% in about a month, which isn't fun at all.

Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.
